UA97658C2 - Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors - Google Patents
Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitorsInfo
- Publication number
- UA97658C2 UA97658C2 UAA200908335A UAA200908335A UA97658C2 UA 97658 C2 UA97658 C2 UA 97658C2 UA A200908335 A UAA200908335 A UA A200908335A UA A200908335 A UAA200908335 A UA A200908335A UA 97658 C2 UA97658 C2 UA 97658C2
- Authority
- UA
- Ukraine
- Prior art keywords
- parp
- adp
- ribose
- polymerase
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
The present invention relates to compounds of formula (I): and pharmaceutically acceptable salts, stereoisomers or tautomers thereof which are inhibitors of poly(ADP-ribose)polymerase (PARP) and thus useful for the treatment of cancer, inflammatory discuses, reperfusion injuries, ischemic conditions, stroke, renal failure, cardiovascular diseases, vascular diseases other than cardiovascular diseases, diabetes, neurodegenerative diseases, retroviral infection, retinal damage or skin senescence and UV-induced skin damage, and as chemo and/or radiosensitizers for cancer treatment.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0700432.8A GB0700432D0 (en) | 2007-01-10 | 2007-01-10 | Therapeutic compounds |
PCT/GB2008/050018 WO2008084261A1 (en) | 2007-01-10 | 2008-01-08 | Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
UA97658C2 true UA97658C2 (en) | 2012-03-12 |
Family
ID=37809722
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200908335A UA97658C2 (en) | 2007-01-10 | 2008-01-08 | Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors |
Country Status (21)
Country | Link |
---|---|
CN (1) | CN101578279B (en) |
AT (1) | ATE502933T1 (en) |
CR (1) | CR10910A (en) |
DE (1) | DE602008005711D1 (en) |
DK (2) | DK2109608T3 (en) |
ES (3) | ES2509115T3 (en) |
GB (1) | GB0700432D0 (en) |
HN (1) | HN2009001260A (en) |
HU (1) | HUE044513T2 (en) |
LT (1) | LT2805945T (en) |
LU (1) | LUC00072I2 (en) |
ME (1) | ME03481B (en) |
MY (1) | MY147789A (en) |
NI (1) | NI200900135A (en) |
NZ (1) | NZ578256A (en) |
PE (1) | PE20081558A1 (en) |
PT (3) | PT2805945T (en) |
SI (2) | SI2336120T1 (en) |
TW (1) | TWI528961B (en) |
UA (1) | UA97658C2 (en) |
ZA (1) | ZA200903898B (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106496187A (en) * | 2016-09-14 | 2017-03-15 | 陕西科技大学 | A kind of synthetic method for preparing PARP inhibitor Niraparib |
CN106432187A (en) * | 2016-09-17 | 2017-02-22 | 青岛云天生物技术有限公司 | Chiral resolution method of 2-[4-(-3-piperidyl)phenyl]-2H-indazole-7-formamide |
CN106432188A (en) * | 2016-09-17 | 2017-02-22 | 青岛辰达生物科技有限公司 | Preparation method of anti-cancer drug 2-[4-((3S)-3-Piperidinyl) phenyl]-2H-Indazole-7-Formamide |
CN106632244A (en) * | 2016-09-30 | 2017-05-10 | 陕西科技大学 | A novel synthetic method for preparing an anticancer medicine Niraparib |
CN106467513A (en) * | 2016-09-30 | 2017-03-01 | 陕西科技大学 | A kind of synthetic method preparing Niraparib |
CN108201537A (en) * | 2016-12-16 | 2018-06-26 | 苏州苏融生物医药有限公司 | A kind of Ni Lapani sustained and controlled release medicaments composition and application thereof |
SG11201908977SA (en) * | 2017-03-27 | 2019-10-30 | Tesaro Inc | Niraparib formulations |
CN109081828B (en) * | 2017-06-14 | 2021-03-26 | 上海时莱生物技术有限公司 | Poly (ADP-ribose) polymerase inhibitor, preparation method and application |
EA202090573A1 (en) | 2017-09-26 | 2020-09-07 | Тесаро, Инк. | COMPOSITIONS OF NIRAPARIBA |
CN108084157A (en) * | 2018-02-12 | 2018-05-29 | 安庆奇创药业有限公司 | A kind of synthetic method of Ni Lapani |
CN108203404A (en) * | 2018-03-02 | 2018-06-26 | 上海博邦医药科技有限公司 | (R) synthetic method of -3- Phenylpiperidines or/and the chiral intermediate of (S) -3- Phenylpiperidines and Ni Lapani |
JP2023514794A (en) | 2020-02-24 | 2023-04-10 | フーカン(シャンハイ) ヘルス テクノロジー カンパニー、 リミテッド | Anticoronavirus application of poly ADP ribose polymerase inhibitors |
CN115611860A (en) * | 2021-07-13 | 2023-01-17 | 上海博璞诺科技发展有限公司 | Method for synthesizing nilapanib |
-
2007
- 2007-01-10 GB GBGB0700432.8A patent/GB0700432D0/en not_active Ceased
-
2008
- 2008-01-08 HU HUE14176452 patent/HUE044513T2/en unknown
- 2008-01-08 MY MYPI20092876A patent/MY147789A/en unknown
- 2008-01-08 NZ NZ578256A patent/NZ578256A/en unknown
- 2008-01-08 PT PT14176452T patent/PT2805945T/en unknown
- 2008-01-08 UA UAA200908335A patent/UA97658C2/en unknown
- 2008-01-08 PT PT111573697T patent/PT2336120E/en unknown
- 2008-01-08 PE PE2008000097A patent/PE20081558A1/en active IP Right Grant
- 2008-01-08 AT AT08702101T patent/ATE502933T1/en active
- 2008-01-08 CN CN2008800019265A patent/CN101578279B/en active Active
- 2008-01-08 SI SI200831266T patent/SI2336120T1/en unknown
- 2008-01-08 ES ES11157369.7T patent/ES2509115T3/en active Active
- 2008-01-08 LT LTEP14176452.2T patent/LT2805945T/en unknown
- 2008-01-08 PT PT08702101T patent/PT2109608E/en unknown
- 2008-01-08 DK DK08702101.0T patent/DK2109608T3/en active
- 2008-01-08 SI SI200830240T patent/SI2109608T1/en unknown
- 2008-01-08 DK DK11157369.7T patent/DK2336120T3/en active
- 2008-01-08 TW TW097100730A patent/TWI528961B/en active
- 2008-01-08 ES ES14176452T patent/ES2728199T3/en active Active
- 2008-01-08 DE DE602008005711T patent/DE602008005711D1/en active Active
- 2008-01-08 ES ES08702101T patent/ES2362214T3/en active Active
- 2008-01-08 ME MEP-2019-147A patent/ME03481B/en unknown
-
2009
- 2009-06-04 ZA ZA200903898A patent/ZA200903898B/en unknown
- 2009-07-02 HN HN2009001260A patent/HN2009001260A/en unknown
- 2009-07-02 CR CR10910A patent/CR10910A/en unknown
- 2009-07-02 NI NI200900135A patent/NI200900135A/en unknown
-
2018
- 2018-05-03 LU LU00072C patent/LUC00072I2/en unknown
Also Published As
Publication number | Publication date |
---|---|
PT2109608E (en) | 2011-05-30 |
PT2805945T (en) | 2019-06-06 |
SI2336120T1 (en) | 2014-10-30 |
CN101578279B (en) | 2013-07-17 |
CN101578279A (en) | 2009-11-11 |
HUE044513T2 (en) | 2019-10-28 |
CR10910A (en) | 2010-01-19 |
NI200900135A (en) | 2010-08-30 |
ES2728199T3 (en) | 2019-10-22 |
MY147789A (en) | 2013-01-31 |
LUC00072I2 (en) | 2018-07-04 |
PE20081558A1 (en) | 2008-10-30 |
TW200836731A (en) | 2008-09-16 |
ATE502933T1 (en) | 2011-04-15 |
GB0700432D0 (en) | 2007-02-21 |
HN2009001260A (en) | 2012-03-26 |
NZ578256A (en) | 2011-12-22 |
LT2805945T (en) | 2019-06-25 |
DE602008005711D1 (en) | 2011-05-05 |
SI2109608T1 (en) | 2011-07-29 |
ZA200903898B (en) | 2010-04-28 |
ES2509115T3 (en) | 2014-10-17 |
TWI528961B (en) | 2016-04-11 |
DK2109608T3 (en) | 2011-07-11 |
DK2336120T3 (en) | 2014-10-06 |
ME03481B (en) | 2020-01-20 |
ES2362214T3 (en) | 2011-06-29 |
PT2336120E (en) | 2014-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009007200A (en) | Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors. | |
ZA200903898B (en) | Amide substituted indazoles as poly (ADP-Ribose)polymerase (PARP) inhibitors | |
MX2010005070A (en) | Pyridazinone derivatives as parp inhibitors. | |
WO2007138351A3 (en) | Pyridinone and pyridazinone derivatives as inhibitors of poly(adp-ribose)polymerase (parp) | |
WO2008103277A3 (en) | Nitrogen-containing heterocyclyl ketones and their use as c-met inhibitors | |
MX2013001204A (en) | Compounds for the treatment/prevention of ocular inflammatory diseases. | |
ATE543811T1 (en) | PYRIDAZINE DERIVATIVES AS FACTOR XIA INHIBITORS | |
EA201190158A1 (en) | Derivatives of benzofuranyl for use as glucose kinase inhibitors | |
WO2010045251A3 (en) | Spiro-oxindole compounds and their use as therapeutic agents | |
MX2011011854A (en) | Dihydropyrimidinones for use as bace2 inhibitors. | |
MX2012001838A (en) | Heterocyclic hydrazone compounds and their uses to treat cancer and inflammation. | |
WO2008017883A3 (en) | 4-oxo-4,5-dihydropyrrolo[1,2-a] quinoxaline derivatives as inhibitors of poly(adp-ribose)polymerase(parp) | |
EA201070864A1 (en) | NEW HETEROCYCLIC COMPOUNDS | |
MX2012007582A (en) | 4-phenoxy-nicotinamide or 4-phenoxy-pyrimidine-5-carboxamide compounds. | |
WO2011147951A8 (en) | Cycloamino derivatives as gpr119 agonists | |
MX2011013869A (en) | Anthelmintic agents and their use. | |
PH12015500418A1 (en) | Pyridine derivative and medicine | |
GB201114389D0 (en) | Novel compounds | |
TR201901937T4 (en) | 8-methyl-1-phenyl-imidazole [1,5-a] pyrazine compounds. |